+86-21-54286005 info@tenmed.net Room 602, Building 1, No. 111 Luxiang Road (Greenland Park Plaza), Baoshan District, Shanghai, China
Language: English

LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

COVIDIEN LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

Phone:+86-21-54286005

Resources

LF1930T_Brochure_EN

OVERVIEW

Reliable vessel-sealing technology

Tailored for Thoracic Surgery

The LigaSure™ Maryland jaw thoracic sealer/divider is part of our commitment to transforming lung care.


It’s the first — and only — minimally invasive LigaSure™ device designed for VATS procedures and indicated for sealing pulmonary veins and arteries up to and including 7 mm.1-5,6

The multifunctional LigaSure™ Maryland jaw thoracic device complements thoracic procedures by providing:

  • One-step vessel sealing7
  • Enhanced blunt dissection8,9,†
  • Secure, atraumatic grasping8,9,†
  • Cold cutting independent of sealing7,8
The LigaSure™ Technology Difference

Reliable LigaSure™ vessel-sealing technology drives the LigaSure™ thoracic device. It works by using the body’s own collagen and elastin to create a permanent seal that is designed to withstand three times normal pulmonary systolic blood pressure.3

Plus, LigaSure™ technology eliminates the guesswork — and minimizes thermal spread8,10,‡ — by automatically discontinuing energy delivery when the seal cycle is complete.11

 

  • † 31 of 33 surgeons surveyed after use agreed. Compared to straight jaws.
  •  ‡ Based on systemic vasculature. Compared to Olympus Thunderbeat™*.
  • 1. Based on internal report #RE00138840, LIG-45 memo, device length recommendation, thoracic (LF1930T). Feb. 6, 2018.
  • 2. Based on internal test report #RE00125866, Jaw range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on tissue. Nov. 20–21, 2017 and Nov. 27–30, 2017.
  • 3. Based on internal test report #RE00134865, Burst pressure verification of pulmonary veins (LF1930T). Jan. 17–18, 2018.
  • 4. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.
  • 5. Based on internal test report #RE00128442, GLP Acute pulmonary vasculature hemostasis verification study of the LF1930T in hounds. Dec. 8, 2017.
  • 6. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.
  • 7. LigaSure™ Maryland jaw thoracic sealer/divider one-step sealing, nano-coated [instructions for use]. Boulder, CO: Medtronic; 2018.
  • 8. Based on internal test report #RE00140529 rev A, LigaSure™ Maryland device, nano-coated (LF19XX) tissue testing (memo). March 5, 2018.
  • 9. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
  • 10. Based on internal report # R0047634_A, Comparison of various competitor devices versus the Sonicision™ device and LigaSure™ LF1637 and LF1737 devices; acute porcine study. Nov. 11 and 18, 2013, and Dec. 9, 2013.
  • 11. Based on internal test report #RE00025819 rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.
Order Information
PRODUCT CODE DESCRIPTION UNIT OF MEASURE QUANTITY
LF1930T LigaSure™ Maryland Jaw Thoracic Sealer/ Divider (30 cm) Box 6
Specifications
GENERATOR COMPATIBILITY Valleylab™ FT10 Energy Platform

选择您的地区和语言

产品和促销活动可能因您选择的地区而异。